This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.
"synopsis" may belong to another edition of this title.
I have completed my MSc. program in Strategic Project Management (European). My research interests are in the areas of financial economics specifically on Efficient Market Hypothesis, and capital budgeting for making investment decisions under uncertain business environment, by capturing the value of new information, and managerial flexibility.
"About this title" may belong to another edition of this title.
US$ 26.57 shipping from Germany to U.S.A.
Destination, rates & speedsSeller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry. 76 pp. Englisch. Seller Inventory # 9783844310030
Quantity: 2 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry. Seller Inventory # 9783844310030
Quantity: 1 available
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: GUPTA MAYANKI have completed my MSc. program in Strategic Project Management (European). My research interests are in the areas of financial economics specifically on Efficient Market Hypothesis, and capital budgeting for making in. Seller Inventory # 5471481
Quantity: Over 20 available
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. Neuware -This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associated with the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.Books on Demand GmbH, Überseering 33, 22297 Hamburg 76 pp. Englisch. Seller Inventory # 9783844310030
Quantity: 2 available